NASDAQ:KTRA

Kintara Therapeutics (KTRA) Earnings Date, Estimates & Call Transcripts

$3.47

+0.37 (+11.94%)

(As of 06/2/2023 ET)

Compare

Today's Range: $3.14
▼
$3.98
50-Day Range: $2.77
▼
$4.36
52-Week Range: $2.70
▼
$20.00

Volume: 107,616 shs
Average Volume: 24,196 shs
Market Capitalization: $5.86 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Upcoming Earnings Date: Sep. 26Estimated
Actual EPS (May. 11): -$1.94 Missed By -$1.84
Consensus EPS (May. 11): -$0.10
Last Year's Q2 EPS (5/13/2022): -$5.50

Earnings Per Share Revenue

KTRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KTRA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Kintara Therapeutics Analyst Forecasts

Current Year EPS Consensus Estimate: $-4.29 EPS
Next Year EPS Consensus Estimate: $-0.5 EPS

KTRA Earnings Date and Information

Kintara Therapeutics last posted its quarterly earnings data on May 11th, 2023. The reported ($1.94) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by $1.84. Kintara Therapeutics has generated ($11.04) earnings per share over the last year (($11.04) diluted earnings per share). Earnings for Kintara Therapeutics are expected to grow in the coming year, from ($4.29) to ($0.50) per share. Kintara Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 26th, 2023 based off prior year's report dates.

Kintara Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS
9/26/2023 (Estimated)
5/11/2023	Q3 2023	($0.10)	($1.94)	($1.84)	($1.94)
2/14/2023	Q2 2023	($2.80)	($2.10)	+$0.70	($2.10)
11/9/2022	Q1 2023		($3.50)	($3.50)	($0.07)
9/27/2022	Q4 2022	($1.50)	($3.50)	($2.00)	($0.07)
5/13/2022	Q3 2022	($5.50)	($5.50)		($0.11)
2/11/2022	Q2 2022	($9.00)	($6.00)	+$3.00	($0.12)

11/15/2021	9/30/2021	($7.00)	($8.50)	($1.50)	($0.25)
9/28/2021	6/30/2021	($8.00)	($6.50)	+$1.50	($0.13)
5/14/2021	3/31/2021	($9.00)	($11.50)	($2.50)	($0.23)
2/11/2021	12/31/2020	($7.00)	($11.00)	($4.00)	($0.22)
11/13/2020	Q1 2021	($1.50)	($19.50)	($18.00)	$0.55
9/21/2020	Q4 2020	($4.50)	($12.50)	($8.00)	($0.15)
5/13/2020	Q3 2020	($2.50)	($8.50)	($6.00)	($0.17)
5/13/2020	3/31/2020	($5.50)	($8.50)	($3.00)	($0.17)
2/13/2020	Q2 2020		($7.50)	($7.50)	($0.15)
2/13/2020	Q2	($8.75)	($7.50)	+$1.25	($0.15)
11/13/2019	Q1 2020	($20.00)	($10.50)	+$9.50	($0.21)
11/13/2019	Q1 2020	($20.00)	($10.50)	+$9.50	($0.21)
9/10/2019	Q4 2019	($15.00)	($44.50)	($29.50)	($0.89)
9/10/2019	Q4 2019	($15.00)	($44.50)	($29.50)	($0.89)
5/15/2019	Q3 2019		($33.50)	($33.50)	($0.67)
5/15/2019	Q3 2019		($33.50)	($33.50)	($0.67)
2/11/2019	Q2 2019		($40.00)	($40.00)	($0.80)
2/11/2019	Q2 2019		($40.00)	($40.00)	($0.08)
11/13/2018	Q1 2019		($45.00)	($45.00)	($0.90)
11/13/2018	9/30/2018	($40.00)	($45.00)	($5.00)	($0.09)
9/24/2018	Q4 2018	($55.00)	($50.00)	+$5.00	($1.00)
9/24/2018	6/30/2018	($55.00)	($50.00)	+$5.00	($0.10)
5/15/2018	Q3 2018	($50.00)	($65.00)	($15.00)	($1.30)
5/15/2018	Q3	($50.00)	($65.00)	($15.00)	($0.13)
2/15/2018	Before Market	($75.00)	($70.00)	+$5.00	($0.14)
2/14/2018	Q2 2018	($75.00)	($70.00)	+$5.00	($1.40)
11/13/2017		($85.00)	($90.00)	($5.00)	($0.18)
11/9/2017	Q1 2018	($85.00)	($90.00)	($5.00)	($1.80)
9/27/2017	Q4 2017	($95.00)	($100.00)	($5.00)	($2.00)
9/27/2017	Q4 2017	($95.00)	($100.00)	($5.00)	($0.20)
5/18/2017		($90.00)	($90.00)		($0.18)
5/12/2017	Q3 2017	($90.00)	($90.00)		($1.80)
2/10/2017	Q2 2017	($85.00)	($65.00)	+$20.00	($1.30)
2/10/2017	12/31/2016	($110.00)	($65.00)	+$45.00	($0.13)

11/10/2016	Q1 2017	($75.00)	($115.00)	($40.00)	($2.30)
11/10/2016	9/30/2016	($75.00)	($115.00)	($40.00)	($0.23)
9/13/2016	Q4 2016	($85.00)	($85.00)		($0.20)
9/13/2016	Q4 2016	($85.00)	($85.00)		($0.02)
5/12/2016	Q3 2016	($80.00)	($60.00)	+$20.00	($1.20)
5/12/2016	Q3 2016	($80.00)	($60.00)	+$20.00	($0.12)
2/16/2016	Q2 2016	($60.00)	($120.00)	($60.00)	($2.40)
2/16/2016	Q2 16	($15.00)	($30.00)	($15.00)	($0.06)
11/16/2015	Q1 2016	($60.00)	($80.00)	($20.00)	($1.60)
11/16/2015	Q1 2016	($60.00)	($80.00)	($20.00)	($0.16)
9/4/2015	Q4 2015	($180.00)	($40.00)	+$140.00	($0.80)
9/4/2015	Q4 2015	($45.00)	($10.00)	+$35.00	($0.02)
5/15/2015	Q3 2015	($140.00)	($80.00)	+$60.00	($1.60)
5/15/2015	Q3 2015	($35.00)	($20.00)	+$15.00	($0.04)
2/12/2015	Q2 2015	($120.00)	($60.00)	+$60.00	($1.20)
2/12/2015	Q2 2015	($30.00)	($15.00)	+$15.00	($0.03)
11/10/2014	Q1 2015	($140.00)	($80.00)	+$60.00	($1.60)
11/10/2014	Q1 2015	($35.00)	($20.00)	+$15.00	($0.04)

Kintara Therapeutics Earnings - Frequently Asked Questions

When is Kintara Therapeutics's earnings date?: Kintara Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 26th, 2023 based off last year's report dates. Learn more on KTRA's earnings history.
Did Kintara Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Kintara Therapeutics (NASDAQ:KTRA) missed the analysts' consensus estimate of ($0.10) by $1.84 with a reported earnings per share (EPS) of ($1.94). Learn more on analysts' earnings estimate vs. KTRA's actual earnings.

How much profit does Kintara Therapeutics generate each year?: Kintara Therapeutics (NASDAQ:KTRA) has a recorded net income of -$22.66 million. KTRA has generated -$11.04 earnings per share over the last four quarters.
What is Kintara Therapeutics's EPS forecast for next year?: Kintara Therapeutics's earnings are expected to grow from ($4.29) per share to ($0.50) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:KTRA) was last updated on 6/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Kintara Therapeutics (KTRA) Earnings Date, Estimates & Call Transcripts

KTRA Earnings Estimates and Actuals by Quarter

KTRA Estimated and Actual Revenue by Quarter

Kintara Therapeutics Analyst Forecasts

KTRA Earnings Date and Information

Kintara Therapeutics Earnings History by Quarter

Kintara Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Kintara Therapeutics (KTRA) Earnings Date, Estimates & Call Transcripts

Earnings Summary

KTRA Earnings Estimates and Actuals by Quarter

KTRA Estimated and Actual Revenue by Quarter

Kintara Therapeutics Analyst Forecasts

KTRA Earnings Date and Information

Kintara Therapeutics Earnings History by Quarter

Kintara Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat